【摘要】 目的　探讨晚期卵巢上皮癌行腹膜后淋巴结清除的价值。方法　８５ 例晚期卵巢上皮癌患者根据清除腹膜后淋巴结与否分成Ａ、Ｂ两组，Ａ 组４２ 例，Ｂ组４３ 例；再将两组患者根据肿瘤细胞减灭术（ 减灭术） 后残瘤灶直径≥２ｃｍ 和＜ ２ｃｍ 分成两组进行比较。结果　两组５ 年存活率分别为３８－１ ％ 和２７－９ ％ （ Ｐ ＜ ０－０５） 。Ａ 组残瘤灶直径＜ ２ｃｍ 与Ｂ组残瘤灶直径＜ ２ｃｍ 存活率分别为５３－８ ％ 和３４－６ ％ （ Ｐ＜ ０－０５） ；Ａ、Ｂ两组残瘤灶直径≥２ｃｍ 存活率分别为１２－５％ 和１７－７％ （ Ｐ＞ ０－０５） 。结论　晚期卵巢上皮性癌在减灭术理想前提下行腹膜后淋巴结清除术可以提高存活率。反之，若减灭术不理想时，行腹膜后淋巴结清除术不能提高存活率。更多还原

【Abstract】 Objective\ To evaluate retroperitoneal lymphadenectomy for advanced ovarian cancer.Methods\ 85 patients with stage Ⅲ～Ⅳ epithelial ovarian cancer were divided into two groups (A and B).Group A(42 patients) were treated by lymphadenectomy,while group B (43 patients)were not.Group A and B were furtherly developed into 2 groups according to whether optimal cytoreductive performed or not.Results\ There is a significant difference in the five-year survival rates between group A and B (38.1% vs 27.9%,P<0 05),also between the two optimal cytoreductive of group A and B (53.8% vs 34.6%,P<0 05),and no sigificant difference between no optimal cytoreductive of these two groups (12 5% vs 17.7%,P>0 05).Conclusions\ On the fundation of the optimal cytoreductive,retroperitoneal lymphadenectomy could increase the five-year survival rate in advanced epithelial ovarian cancer.Retroperitoneal lymphadenectomy should not be performed in advanced epithelial ovarian cancer with no optimal cytoreductive.更多还原